Welcome back to the Diet Doctor Podcast. I'm your host, Dr. Brett Scher.

Today, I've got to admit I'm joined by one of my favorite guests, Dave Feldman.

Now, we've already interviewed Dave Feldman before, and I've interviewed him before when I was

doing my prior podcast, and I'm a bit of a lipid nerd. I love lipidology, I love cholesterol,

and that's where Dave really is on the forefront of a lipid nerd. I love lipidology. I love cholesterol.

And that's where Dave really is on the forefront of the lipidology community,

which is a little surprising because he's not a doctor.

He's not a scientist.

He's not a nutritionist.

He's an engineer.

But he's one of these engineers who's become a citizen scientist.

But he's doing more than just his end of one experiment. He is engaging the community. And now, as we're going to hear something very exciting in this podcast, that he

has orchestrated a study and is ready to start begin enrolling a study on lean mass hyperresponder.

So stay tuned for that. We get to that about halfway through the episode where you can hear more about this. But what is lean mass hyperresponder. So stay tuned for that. We get to that about halfway through the episode

where you can hear more about this. But what is lean mass hyper responder? Let's start with that.

Basically, it's an elevation in LDL cholesterol that happens when someone's following a low-carb diet.

Now, as we discuss, there's a lot of discrepancy within the cardiology world, within the lipid

world that you have to assume all elevated

LDL is dangerous, or is this a special circumstance where maybe it's not dangerous? And we have to

be honest that we don't know, right? We don't have the data for that. And that's where Dave is really

trying to make a difference to get us that data, which is so exciting. But he's got his lipid hypothesis, which if you haven't, if this is your first exposure to Dave,

I recommend you go to cholesterol code.com.

...